Clonal Hematopoiesis Mutations and Cell-Free DNA Characteristics in Patients with High-Risk Large B-Cell Lymphomas
Miro Nylén(University of Helsinki), Mikko Myllymäki(University of Helsinki), Lars Møller Pedersen(Hospital South West Jutland), Øystein Fluge(Haukeland University Hospital), Judit Mészáros Joergensen(Aarhus University Hospital), Mats Jerkeman(Skåne University Hospital), Maare Arffman(University of Helsinki), Peter de Nully Brown(Copenhagen University Hospital), Mikael Eriksson(Herlev Hospital), Magnus Björkholm(Karolinska Institutet), Sirpa Leppä(University of Helsinki), Harald Holte(Oslo University Hospital), Sirkku Jyrkkiö(Turku University Hospital), Leo Meriranta(University of Helsinki), Emil Hiitola(University of Helsinki), Satu Mustjoki(University of Helsinki)
Cited by 0
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k